(Q42457682)

31 October 2017

title

Variable Bcl-2 phenotype in benign and malignant lesions of urothelium (English)

1 reference

31 October 2017

Bilim VN

1

1 reference

31 October 2017

Tomita Y

2

1 reference

31 October 2017

Kawasaki T

3

1 reference

31 October 2017

Takeda M

4

1 reference

31 October 2017

Takahashi K

5

1 reference

31 October 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

31 October 2017

1 reference

31 October 2017

volume

128

1 reference

31 October 2017

issue

1

1 reference

31 October 2017

page(s)

87-92

1 reference

Mapping of the human BAX gene to chromosome 19q13.3–q13.4 and isolation of a novel alternatively spliced transcript, BAXδ

31 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900055-X

7 January 2021

Prognostic value of Bcl-2 and p53 expression in urinary tract transitional cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900055-X

7 January 2021

Thymocyte apoptosis induced by p53-dependent and independent pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900055-X

7 January 2021

Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900055-X

7 January 2021

Detection of p53 and bcl-2 protein in carcinoma of the renal pelvis and ureter including dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900055-X

7 January 2021

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900055-X

7 January 2021

Increased expression of mutant forms of p53 oncogene in primary lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900055-X

7 January 2021

mRNA and protein expression of p53 mutations in human bladder cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900055-X

7 January 2021

p53 is required for radiation-induced apoptosis in mouse thymocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900055-X

7 January 2021

Bcl-2 expression in adult and embryonic non-haematopoietic tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900055-X

7 January 2021

Ultrastructural localization of bcl-2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900055-X

7 January 2021

Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900055-X

7 January 2021

Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900055-X

7 January 2021

Frequent expression of Bcl-2 in renal-cell carcinomas carrying wild-type p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900055-X

7 January 2021

Expression of intercellular adhesion molecule-1 (ICAM-1) on renal-cell cancer: possible significance in host immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900055-X

7 January 2021

Correlation of p53 protein expression in human urothelial transitional cell cancers with malignant potential and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900055-X

7 January 2021

p21 is a universal inhibitor of cyclin kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900055-X

7 January 2021

BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2898%2900055-X

7 January 2021

10.1016/S0304-3835(98)00055-X

Identifiers

DOI

1 reference

31 October 2017

1 reference